IMMUTEP LIMITED — Director's Dealing 2010

Jul 26, 2010

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.

Name of Entity: Prima Biomed Limited (ASX: PRR) ABN: 90 009 237 889

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Mr Martin Rogers Date of Appointment: 23 July 2010

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number	Class of Securities
Nil

• See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of Holder	Nature of Interest	Number ofSecurities	Class ofSecurities
Note: Provide details of the circumstances giving rise to the relevant interest
Rogers SF Management Pty Ltd<Rogers Super Fund A/C>	Director Related Entity	479,500	PRRFully paid ordinaryshares
Structure Investments Pty Ltd<Rogers Family A/C>	Director Related Entity	20,342,00012,345,238	PRRFully paid ordinarysharesPRROListedOptionsexercisable at $0.02onorbefore30/12/2011

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	NIL
Nature of interest
	NIL
Name of registered holder
(if issued securities)	NIL
No. and class of securities to
which interest relates	NIL

==> picture [43 x 25] intentionally omitted <==

The CFO Solution

27.07.2010

• See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.

Name of Entity: Prima Biomed Limited (ASX: PRR) ABN: 90 009 237 889

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Dr Neil Frazer Date of Appointment: 23 July 2010

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number	Class of Securities
Nil

• See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of Holder	Nature of Interest	Number ofSecurities	Class ofSecurities
Note: Provide details of the circumstances giving rise to the relevant interest
Nil

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	As per Dr Frazer’s employment contract, subject to DrFrazer exceeding agreed performance targets asdetermined by the Company in its absolute discretion,on the 1stday of February each year during DrFrazer’s employment with the Company, the Companywill grant Mr Frazer 500,000 Performance Options.Vesting of the Performance Options is subject to DrFrazer continuing to be an employee of the Companyfor not less than four years after the grant date of thePerformance Options.Performance Options are exercisable on the dateequal to two years after grant date, at a lesser price often cents per option or a price equal to a 30 dayVWAP of ordinary shares in the Company traded onASX immediately prior to the grant date of thePerformance Options to Dr Frazer.
Nature of interest	Employee
Name of registered holder(if issued securities)	N/A
No. and class of securities towhich interest relates	N/A

==> picture [43 x 25] intentionally omitted <==

The CFO Solution

27.07.2010

• See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002